Sofosbuvir taken before or after liver transplant reduces hepatitis C recurrence - aidsmap | Organ Donation & Transplant Matters Resources | Scoop.it

The new anti-viral agent Sofosbuvir taken either before or after liver transplant reduces hepatitis C recurrence as reported via aidsmap.

 

An interferon-free combination of sofosbuvir plus ribavirin administered before liver transplantation prevented hepatitis C recurrence in nearly

two-thirds of cases as recently reported at the AASLD meeting.

 

Sofosbuvir is just one of a number of new anti-viral oral agents that are being trialled for the treatment of hepatitis C (as pictured in the graphic). Hence this is an encouraging report.

 

The combination of Sofosbuvir with a different anti-viral agent Ledipasvir is reported via the Guardian (post publication in The Lancet )-

 

http://www.theguardian.com/science/2013/nov/05/hope-hepatitis-cure-drugs-success-sofosbuvir-ledipasvir?CMP=twt_gu